Title |
Einsatz von Methadon zur Unterstützung der onkologischen Therapie?
|
---|---|
Published in |
Der Schmerz, January 2017
|
DOI | 10.1007/s00482-016-0183-9 |
Pubmed ID | |
Authors |
H. Hofbauer, M. Schenk, K. Kieselbach, S. Wirz |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2019.
All research outputs
#1,194,562
of 22,988,380 outputs
Outputs from Der Schmerz
#7
of 374 outputs
Outputs of similar age
#27,221
of 421,083 outputs
Outputs of similar age from Der Schmerz
#1
of 3 outputs
Altmetric has tracked 22,988,380 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 374 research outputs from this source. They receive a mean Attention Score of 4.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,083 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them